Cathie Wood’s ARK Invest cashed in on the pop in price that Signify Health, Inc. ( NYSE: SGFY ) experienced on Tuesday, as the popular fund manager sold more than 1.6M shares of the stock.
SGFY gained 32.1% on Tuesday after reports surfaced that the home health service provider intends to conduct a board meeting to evaluate multiple buyout offers.
Wood and her team were able to capture some profits as her flagship fund ARK Innovation ETF ( NYSEARCA: ARKK ) sold 1,069,686 shares of SGFY and ARK Genomic Revolution ETF ( BATS: ARKG ) unloaded 642,230 shares. Data is per ARK’s daily disclosed trade records.
SGFY is owned by 41 different exchange traded funds but Wood’s ARKG and ARKK are the two funds with the largest stakes in the Dallas-based firm. ARKG classifies SGFY as the fund’s top holding with a weighting of 7.30%. At the same time, ARKK has SGFY as its 16 th most significant position with a 2.93% holding.
From a market value stance, ARKK has a $237.84M claim in Signify Health, while ARKG has a $197.69M position in the organization.
Year-to-date price action: SGFY +86.2% , ARKK -55.1% , and ARKG -42.8% .
With buyout talks for SGFY rumbling around the market, potential buyers have found themselves jockeying for position.
For further details see:
Cathie Wood cashed in on some profits thanks to the spike in SGFY